Exploring the impact of NGS on diagnostics and treatment of sarcoma: insights from real-world data across multiple institutions in Europe

In conclusion, our data support the clinical utility of NGS fusion panels in diagnosing sarcomas in specific contexts. The therapeutic value of NGS remains limited, as reported before. However, given the overall paucity of molecular data for most sarcoma subtypes, we emphasize the importance of an international effort to collect molecular profiling of sarcomas to guide the design of clinical trials for specific targetable alterations.

Authors

Institutions

Publication Details

Journal
ESMO Open
Published
2025-09-01
DOI
https://doi.org/10.1016/j.esmoop.2025.105577
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring the impact of NGS on diagnostics and treatment of sarcoma: insights from real-world data across multiple institutions in Europe

Katarzyna Seliga, C. Serrano, Claudia Valverde, Ioannis Boukovinas et al.
ESMO Open
Sarcoma Diagnosis and Treatment
article

Exploring the impact of NGS on diagnostics and treatment of sarcoma: insights from real-world data across multiple institutions in Europe

Katarzyna Seliga, C. Serrano, Claudia Valverde, Ioannis Boukovinas, Ramiro Álvarez, Magdalena Rosińska, Tania Silva, Iwona Ługowska, Anastasios Kyriazoglou, Cleofé Romagosa, Michał Wągrodzki, Anna Malgorzata Czarnecka, A Mala, Stefania Kokkali, M. Witczak, Andrzej Tysarowski, Asimina Koulouridi, Agnieszka Zając, P. Rutkowski, Vassilis Georgoulias, Piotr Błoński, M Aguirre
article en

Abstract

In conclusion, our data support the clinical utility of NGS fusion panels in diagnosing sarcomas in specific contexts. The therapeutic value of NGS remains limited, as reported before. However, given the overall paucity of molecular data for most sarcoma subtypes, we emphasize the importance of an international effort to collect molecular profiling of sarcomas to guide the design of clinical trials for specific targetable alterations.

ESMO OpenVol. 10(9)
Hospital General Universitario Gregorio Marañón (ES), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), Polyclinic General Hospital (GR)
Openalex Percentile: Top 65%
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.